Case Reports in Oncology · 2011 · 11 citations · 23 references
MedicineOncologyUrologyChemotherapyMetastasisUrologic OncologyBladder CancerCentral Nervous System TumorsMetastatic Cancer ManagementMetastatic Urologic CancerCarcinomatous MeningitisCentral Nervous System MetastasisIntrathecal MethotrexateMetastatic Bladder CancerMethotrexate ProphylaxisNeoplastic MeningitisSurvival Rates
Carcinomatous meningitis due to bladder cancer is a rare entity reported only in case reports. Optimal therapy is thus poorly defined with earlier cases reporting an unsuccessful outcome. Here we report a case of late carcinomatous meningitis secondary to transitional cell carcinoma (TCC) of the bladder occurring in a patient in complete remission. He was successfully treated with intrathecal methotrexate and whole brain irradiation and experienced prolonged survival after treatment. With modern chemotherapy increasing complete remissions and survival rates in patients with TCC, more and more patients are being reported with carcinomatous meningitis. We raise the question of whether central nervous system prophylaxis should be considered in patients with TCC achieving a complete remission to chemotherapy in the metastatic setting.
23
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text
Medicine, Oncology, Pharmacology +11
Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson et al. · Journal of Clinical Oncology · 1992 · 987 citations
Medicine, Oncology, Pharmacology +12